Single cell sequencing and computational findings reveal anti-estrogen receptor-positive breast cancer roles of formononetin
Abstract Breast cancer is the second leading cancer type in women, accounting for 11.6% of all cancers. Recently, its incidence has increased in younger individuals. Estrogen receptors (ERs) play important roles in the development and progression of breast cancer by controlling hormone signaling. Th...
Saved in:
| Main Authors: | Bihui Li, Shuangxi Li, Ruihan Li, Menzhen Li, Zhaoquan Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06133-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems
by: Min Jin, et al.
Published: (2025-03-01) -
Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
by: Xiaotong Wang, et al.
Published: (2024-11-01) -
Action of Estrogen In Breast Cancer: A review Study
by: Suad Ibrahim, et al.
Published: (2022-10-01) -
Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis
by: Zhenghao Wu, et al.
Published: (2025-08-01) -
Research Progress of Estrogen Receptor in Ovarian Cancer
by: Mengchen Zhang, et al.
Published: (2023-09-01)